Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leflunomide in Methotrexate Refractory Juvenile Idiopathic Arthritis
NCT02024334Phase 4Unknown
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jun 2013
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of leflunomide in juvenile idiopathic arthritis (JIA), sponsored by Mashhad University of Medical Sciences. Status: unknown.
02
Drugs
leflunomide
03
Conditions
juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on NCT02024334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02024334.